Developments in our understanding of the effects of growth hormone on white adipose tissue from mice: implications to the clinic

References

• Prunet-Marcassus B, Cousin B, Caton D, et al. From heterogeneity to plasticity in adipose tissues: site-specific differences. Exp Cell Res. 2006;312(6):727–736.
   PubMed Web of Science ®Google Scholar
• Huh JY, Park YJ, Ham M, et al. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells. 2014;37(5):365–371.
   PubMed Web of Science ®Google Scholar
• Chazenbalk G, Bertolotto C, Heneidi S, et al. Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem cells and adipocytes: evidence of cell plasticity. PLoS One. 2011;6(3):e17834.
   PubMed Web of Science ®Google Scholar
• Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity (Silver Spring). 2015;23(3):512–518.
   PubMed Web of Science ®Google Scholar
• Deiuliis J, Shah Z, Shah N, et al. Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers. PLoS One. 2011;6(1):e16376.
   PubMed Web of Science ®Google Scholar
• Hausman GJ, Dodson MV. Stromal vascular cells and adipogenesis: cells within adipose depots regulate adipogenesis. J Genomics. 2013;1:56–66.
   PubMedGoogle Scholar
• Bertola A, Ciucci T, Rousseau D, et al. Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients. Diabetes. 2012;61(9):2238–2247.
   PubMed Web of Science ®Google Scholar
• Winer DA, Winer S, Shen L, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med. 2011;17(5):610–617.
   PubMed Web of Science ®Google Scholar
• Sepe A, Tchkonia T, Thomou T, et al. Aging and regional differences in fat cell progenitors - a mini-review. Gerontology. 2011;57(1):66–75.
   PubMed Web of Science ®Google Scholar
• Billon N, Dani C. Developmental origins of the adipocyte lineage: new insights from genetics and genomics studies. Stem Cell Rev. 2012;8(1):55–66.
   PubMed Web of Science ®Google Scholar
• Von Der Weid P-Y, Rainey KJ. Review article: lymphatic system and associated adipose tissue in the development of inflammatory bowel disease. Aliment Pharmacol Ther. 2010;32(6):697–711.
   PubMed Web of Science ®Google Scholar
• Gehrke S, Brueckner B, Schepky A, et al. Epigenetic regulation of depot-specific gene expression in adipose tissue. PLoS One. 2013;8(12):e82516.
   PubMed Web of Science ®Google Scholar
• Betz MJ, Enerbäck S. Human brown adipose tissue: what we have learned so far. Diabetes. 2015;64(7):2352–2360.
   PubMed Web of Science ®Google Scholar
• Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360(15):1509–1517.
   PubMed Web of Science ®Google Scholar
• Divoux A, Tordjman J, Lacasa D, et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes. 2010;59(11):2817–2825.
   PubMed Web of Science ®Google Scholar
• Khan T, Muise ES, Iyengar P, et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol. 2009;29(6):1575–1591.
   PubMed Web of Science ®Google Scholar
• Sun K, Tordjman J, Clément K, et al. Fibrosis and adipose tissue dysfunction. Cell Metab. 2013;18(4):470–477.
   PubMed Web of Science ®Google Scholar
• Londos C, Brasaemle DL, Schultz CJ, et al. Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol. 1999;10(1):51–58.
   PubMed Web of Science ®Google Scholar
• Childs GV, Akhter N, Haney A, et al. The somatotrope as a metabolic sensor: deletion of leptin receptors causes obesity. Endocrinology. 2011;152(1):69–81.
   PubMed Web of Science ®Google Scholar
• Watts SW. Trash talk by fat: chemerin as a reactive oxygen species provocateur in the vasculature. Hypertension. 2015;66(3):466–468.
   PubMed Web of Science ®Google Scholar
• Neves KB, Nguyen Dinh Cat A, Lopes RAM, et al. Chemerin regulates crosstalk between adipocytes and vascular cells through Nox. Hypertension. 2015;66(3):657–666.
   PubMed Web of Science ®Google Scholar
• Rao RR, Long JZ, White JP, et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 2014;157(6):1279–1291.
   PubMed Web of Science ®Google Scholar
• Li Z-Y, Zheng S-L, Wang P, et al. Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression. CNS Neurosci Ther. 2014;20(4):344–354.
   PubMed Web of Science ®Google Scholar
• Tchkonia T, Zhu Y, Van Deursen J, et al. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123(3):966–972.
   PubMed Web of Science ®Google Scholar
• Møller N, Jørgensen JO. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev. 2009;30(2):152–177.
   PubMed Web of Science ®Google Scholar
• Brooks AJ, Dai W, O’Mara ML, et al. Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science. 2014;344(6185):1249783.
   PubMed Web of Science ®Google Scholar
• Laron Z, Blum W, Chatelain P, et al. Classification of growth hormone insensitivity syndrome [editorial]. J Pediatr. 1993;122(2):241.
   PubMed Web of Science ®Google Scholar
• Steuerman R, Shevah O, Laron Z. Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. Eur J Endocrinology/European Fed Endocr Societies. 2011;164(4):485–489.
   PubMed Web of Science ®Google Scholar
• Laron Z, Ginsberg S, Lilos P, et al. Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clin Endocrinol (Oxf). 2006;65(1):114–117.
   PubMed Web of Science ®Google Scholar
• Guevara-Aguirre J, Rosenbloom AL, Balasubramanian P, et al. GH receptor deficiency in ecuadorian adults is associated with obesity and enhanced insulin sensitivity. J Clin Endocrinol Metab. 2015;100(7):2589–2596.
   PubMed Web of Science ®Google Scholar
• Kanety H, Hemi R, Ginsberg S, et al. Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity. Eur J Endocrinol. 2009;161(6):837–844.
   PubMed Web of Science ®Google Scholar
• Laron Z, Silbergeld A, Lilos P, et al. Serum leptin in obese patients with Laron syndrome before and during IGF-I treatment. J Pediatr Endocrinol Metab. 1998;11(5):653–656.
   PubMed Web of Science ®Google Scholar
• Gomes-Santos E, Salvatori R, Ferrão TO, et al. Increased visceral adiposity and cortisol to cortisone ratio in adults with congenital lifetime isolated GH deficiency. J Clin Endocrinol Metabolism. 2014;99(9):3285–3289.
   PubMed Web of Science ®Google Scholar
• Pereira RM, Aguiar-Oliveira MH, Sagazio A, et al. Heterozygosity for a mutation in the growth hormone-releasing hormone receptor gene does not influence adult stature, but affects body composition. J Clin Endocrinol Metab. 2007;92(6):2353–2357.
   PubMed Web of Science ®Google Scholar
• Aguiar-Oliveira MH, Oliveira FT, Pereira RMC, et al. Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J Clin Endocrinol Metab. 2010;95(2):714–721.
   PubMed Web of Science ®Google Scholar
• Vicente TAR, Rocha IES, Salvatori R, et al. Lifetime congenital isolated GH deficiency does not protect from the development of diabetes. Endocr Connect. 2013;2(2):112–117.
   PubMedGoogle Scholar
• Chaves VE, Júnior FM, Bertolini GL. The metabolic effects of growth hormone in adipose tissue. Endocrine. 2013;44(2):293–302.
   PubMed Web of Science ®Google Scholar
• Ukropec J, Penesová A, Skopková M, et al. Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and the whole body metabolic derangements. J Clin Endocrinol Metab. 2008;93(6):2255–2262.
   PubMed Web of Science ®Google Scholar
• Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(6):1587–1609.
   PubMed Web of Science ®Google Scholar
• Melmed S. Acromegaly pathogenesis and treatment. J Clin Invest. 2009;119(11):3189–3202.
   PubMed Web of Science ®Google Scholar
• Reyes-Vidal CM, Mojahed H, Shen W, et al. Adipose tissue redistribution and ectopic lipid deposition in active acromegaly and effects of surgical treatment. J Clin Endocrinol Metab. 2015;100(8):2946–2955.
   PubMed Web of Science ®Google Scholar
• Ciresi A, Amato MC, Pizzolanti G, et al. Serum visfatin levels in acromegaly: correlation with disease activity and metabolic alterations. Growth Hormone IGF Research. 2015;25(5):240–246.
   PubMed Web of Science ®Google Scholar
• Olarescu NC, Ueland T, Lekva T, et al. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly. J Clin Endocrinol Metab. 2012;97(4):1355–1362.
   PubMed Web of Science ®Google Scholar
• Luque RM, Lin Q, Córdoba-Chacón J, et al. Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes. PLoS One. 2011;6(1):e15767.
   PubMed Web of Science ®Google Scholar
• List EO, Berryman DE, Funk K, et al. Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles. Endocrinology. 2014;155(5):1793–1805.
   PubMed Web of Science ®Google Scholar
• List EO, Berryman DE, Funk K, et al. The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. Mol Endocrinol. 2013;27(3):524–535.
   PubMed Web of Science ®Google Scholar
• Lu C, Kumar PA, Sun J, et al. Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity. J Biol Chem. 2013;288(22):15725–15735.
   PubMed Web of Science ®Google Scholar
• Berryman DE, List EO, Kohn DT, et al. Effect of growth hormone on susceptibility to diet-induced obesity. Endocrinology. 2006;147(6):2801–2808.
   PubMed Web of Science ®Google Scholar
• Berryman DE, List EO, Coschigano KT, et al. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm IGF Res. 2004;14(4):309–318.
   PubMed Web of Science ®Google Scholar
• Wiesenborn DS, Menon V, Zhi X, et al. The effect of calorie restriction on insulin signaling in skeletal muscle and adipose tissue of Ames dwarf mice. Aging. 2014;6(10):900–912.
   PubMedGoogle Scholar
• Brown-Borg HM, Bartke A. GH and IGF1: roles in energy metabolism of long-living GH mutant mice. J Gerontol A Biol Sci Med Sci. 2012;67A(6):652–660.
   Web of Science ®Google Scholar
• Bartke A, Brown-Borg H. Life extension in the dwarf mouse. Curr Top Dev Biol. 2004;63:189–225.
   PubMed Web of Science ®Google Scholar
• Flurkey K, Papaconstantinou J, Miller RA, et al. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci U S A. 2001;98(12):6736–6741.
   PubMed Web of Science ®Google Scholar
• Fleenor D, Oden J, Kelly PA, et al. Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology. 2005;146(1):103–112.
   PubMed Web of Science ®Google Scholar
• Berryman DE, List EO, Sackmann-Sala L, et al. Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm IGF Res. 2011;21(3):113–123.
   PubMed Web of Science ®Google Scholar
• Menon V, Zhi X, Hossain T, et al. The contribution of visceral fat to improved insulin signaling in Ames dwarf mice. Aging Cell. 2014;13(3):497–506.
   PubMed Web of Science ®Google Scholar
• Richelsen B, Pedersen SB, Kristensen K, et al. Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism. 2000;49(7):906–911.
   PubMed Web of Science ®Google Scholar
• Kraemer FB, Shen W-J. Hormone-sensitive lipase: control of intracellular tri-(di-)acylglycerol and cholesteryl ester hydrolysis. J Lipid Res. 2002;43(10):1585–1594.
   PubMed Web of Science ®Google Scholar
• Yang HL, Sun C, Sun C, et al. Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte. Mol Biol Rep. 2012;39(9):9113–9122.
   PubMed Web of Science ®Google Scholar
• Fain JN, Cheema P, Tichansky DS, et al. Stimulation of human omental adipose tissue lipolysis by growth hormone plus dexamethasone. Mol Cell Endocrinol. 2008;295(1–2):101–105.
   PubMed Web of Science ®Google Scholar
• Nam SY, Lobie PE. The mechanism of effect of growth hormone on preadipocyte and adipocyte function. Obes Rev. 2000;1(2):73–86.
   PubMedGoogle Scholar
• Flint DJ, Binart N, Boumard S, et al. Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity. J Endocrinol. 2006;191(1):101–111.
   PubMed Web of Science ®Google Scholar
• Olarescu NC, Berryman DE, Householder LA, et al. GH action influences adipogenesis of mouse adipose tissue-derived mesenchymal stem cells. J Endocrinol. 2015;226(1):13–23.
   PubMed Web of Science ®Google Scholar
• Masternak MM, Bartke A, Wang F, et al. Metabolic effects of intra-abdominal fat in GHRKO mice. Aging Cell. 2012;11(1):73–81.
   PubMed Web of Science ®Google Scholar
• Lubbers ER, List EO, Jara A, et al. Adiponectin in mice with altered growth hormone action: links to insulin sensitivity and longevity? J Endocrinol. 2012;216(3):363–374.
   Web of Science ®Google Scholar
• Wölfing B, Neumeier M, Buechler C, et al. Interfering effects of insulin, growth hormone and glucose on adipokine secretion. Exp Clin Endocrinol Diabetes. 2008;116(1):47–52.
   PubMed Web of Science ®Google Scholar
• Tchkonia T, Thomou T, Zhu Y, et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 2013;17(5):644–656.
   PubMed Web of Science ®Google Scholar
• Tchkonia T, Morbeck DE, Von Zglinicki T, et al. Fat tissue, aging, and cellular senescence. Aging Cell. 2010;9(5):667–684.
   PubMed Web of Science ®Google Scholar
• Stout MB, Tchkonia T, Pirtskhalava T, et al. Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice. Aging (Albany NY). 2014;6(7):575–586.
   PubMedGoogle Scholar
• Comisford R, Lubbers ER, Householder LA, et al. Growth hormone receptor antagonist transgenic mice have increased subcutaneous adipose tissue mass, altered glucose homeostasis and no change in white adipose tissue cellular senescence. Gerontology. 2015;62(2). [Epub ahead of print]. Available form: http://www.ncbi.nlm.nih.gov/pubmed/26372907
   PubMed Web of Science ®Google Scholar
• Villaret A, Galitzky J, Decaunes P, et al. Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes. 2010;59(11):2755–2763.
   PubMed Web of Science ®Google Scholar
• Hattori N. Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm IGF Res. 2009;19(3):187–197.
   PubMed Web of Science ®Google Scholar
• Lu C, Kumar PA, Fan Y, et al. A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation. Endocrinology. 2010;151(5):2189–2199.
   PubMed Web of Science ®Google Scholar
• Benencia F, Harshman S, Duran-Ortiz S, et al. Male bovine GH transgenic mice have decreased adiposity with an adipose depot-specific increase in immune cell populations. Endocrinology. 2014;156(5):1794–1803. en20141794.
   PubMed Web of Science ®Google Scholar
• Stout MB, Swindell WR, Zhi X, et al. Transcriptome profiling reveals divergent expression shifts in brown and white adipose tissue from long-lived GHRKO mice. Oncotarget. 2015;6(29):26702–26715.
   PubMed Web of Science ®Google Scholar
• Doessing S, Holm L, Heinemeier KM, et al. GH and IGF1 levels are positively associated with musculotendinous collagen expression: experiments in acromegalic and GH deficiency patients. Eur J Endocrinol. 2010;163(6):853–862.
   PubMed Web of Science ®Google Scholar
• Longobardi S, Keay N, Ehrnborg C, et al. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab. 2000;85(4):1505–1512.
   PubMed Web of Science ®Google Scholar
• Amato G, Mazziotti G, Di Somma C, et al. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. J Clin Endocrinol Metab. 2000;85(10):3720–3725.
   PubMed Web of Science ®Google Scholar
• Hazem A, Elamin MB, Bancos I, et al. Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis. Eur J Endocrinology/European Fed Endocr Societies. 2012;166(1):13–20.
   PubMed Web of Science ®Google Scholar
• Meazza C, Elsedfy HH, Pagani S, et al. Metabolic parameters and adipokine profile in growth hormone deficient (GHD) children before and after 12-month GH treatment. Horm Metab Res. 2014;46(3):219–223.
   PubMed Web of Science ®Google Scholar
• Rosenbloom AL. A half-century of studies of growth hormone insensitivity/Laron syndrome: a historical perspective. Growth Horm IGF Res. 2015. doi:10.1016/j.ghir.2015.08.001. [Epub ahead of print]. Available from: http://www.sciencedirect.com/science/article/pii/S1096637415300216
   PubMedGoogle Scholar
• Laron Z, Ginsberg S, Lilos P, et al. Long-term IGF-I treatment of children with Laron syndrome increases adiposity. Growth Horm IGF Res. 2006;16(1):61–64.
   PubMed Web of Science ®Google Scholar
• Guevara-Aguirre J, Rosenbloom AL, Guevara-Aguirre M, et al. Recommended IGF-I dosage causes greater fat accumulation and osseous maturation than lower dosage and may compromise long-term growth effects. J Clin Endocrinol Metabolism. 2013;98(2):839–845.
   PubMed Web of Science ®Google Scholar
• Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. Jama. 2014;311(8):806–814.
   PubMed Web of Science ®Google Scholar
• Berryman DE, Glad CAM, List EO, et al. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations. Nat Rev Endocrinol. 2013;9(6):346–356.
   PubMed Web of Science ®Google Scholar
• Lewitt MS, Dent MS, Hall K. The insulin-like growth factor system in obesity, insulin resistance and type 2 diabetes mellitus. J Clin Med. 2014;3(4):1561–1574.
   PubMedGoogle Scholar
• Franco C, Brandberg J, Lönn L, et al. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J Clin Endocrinol Metab. 2005;90(3):1466–1474.
   PubMed Web of Science ®Google Scholar